Work

MERTK Promotes Resistance to Irreversible EGFR Tyrosine Kinase Inhibitors in Non–small Cell Lung Cancers Expressing Wild-type EGFR Family Members

Year: 2018

Type: article

Source: Clinical Cancer Research

DOI: 10.1158/1078-0432.ccr-18-0040

Authors: Dan Yan, Rebecca E. Parker, Xiaodong Wang, Stephen V. Frye, H. Shelton Earp, Deborah DeRyckere, Douglas K. Graham

Institutions: Emory University, Children's Healthcare of Atlanta, University of North Carolina at Chapel Hill, UNC Lineberger Comprehensive Cancer Center

Language: English

Topic: Lung Cancer Treatments and Mutations

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funders: National Institutes of Health, National Cancer Institute

Awards: G3503792436, G386607036

OpenAlex ID: W2889862256

FWCI: 2.535

Cites: 45

Cited by: 31

Related to: 10